TCTR20201223007已完成1 期
Influence of Lactobacillus paracasei HII01 Supplementation on Glycaemia and Inflammatory biomarkers in Type 2 Diabetes: A Randomized Clinical Trial
Faculty of Pharmacy, Chiang Mai University0 个研究点目标入组 36 人开始时间: 2020年12月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1)Type 2 diabetic patients will be either sex (male or female) between the ages 20 to 70 years.
- •2)Patients who do not take antibiotic drugs for 14 days before starting of the study.
- •3)Patients who can listen, speak, write and read Thai language.
排除标准
- •1)Pregnant or nursing patients
- •3)Patients with abnormal liver function test, ALT > 55 U/L, AST > 34 U/L, ALP > 125 U/L
- •4)Patients with abnormal renal function test, GFR ≤ 60 ml/min
- •5)Patients with history of malignant
- •6)Patients with micro and macro vascular complications
- •7)Patients with uncontrollable emotions which approved by the behavioral and cognitive test and physician
- •8)Patients with thyroid disorder or the endocrine metabolic disorders
- •9)Patients with chronic alcoholic or frequency ≥ 2 times/weeks
研究者
相似试验
已完成
不适用
The effect of Lactobacilli on the immune system of healthy adultsISRCTN08280229Chr. Hansen A/S (Denmark)1,058
进行中（未招募）
不适用
The effect of a diary product with a probiotic on immune response to influenza vaccination in healthy adult volunteers - a multi-center, randomized, placebo-controlled, parallel-group study with six weeks interventioEUCTR2011-003089-34-DEChr. Hansen A/S1,058
已完成
不适用
The effect of probiotics:Lactobacillus casei YIT 9029 (Shirota strain)for the gutmicrobiota of type 2 diabetesJPRN-UMIN000016510Juntendo University70
已完成
不适用
The effect of probiotics:Lactobacillus casei YIT 9029 (Shirota strain)for the gutmicrobiota of type 2 diabetesType 2 diabetesJPRN-UMIN000018246Department of Probiotics, Juntendo University70
已完成
不适用
L. Casei DG® in Patients With Irritable Bowel Syndrome.IBS - Irritable Bowel SyndromeNCT03449628SOFAR S.p.A.264